Antimicrobial Activity of Syzygium aromaticum Essential Oil in Human Health Treatment.
Valentina MagginiGiulia SemenzatoEugenia GalloAlessia NunziataRenato FaniAlfredo VannacciPublished in: Molecules (Basel, Switzerland) (2024)
The use of natural compounds to prevent and treat infective diseases is increasing its importance, especially in the case of multidrug-resistant (MDR) microorganisms-mediated infections. The drug resistance phenomenon is today a global problem, so it is important to have available substances able to counteract MDR infections. Syzygium aromaticum (L.) Merr. & L.M. Perry (commonly called clove) is a spice characterized by several biological properties. Clove essential oil (EO) consists of numerous active molecules, being eugenol as the principal component; however, other compounds that synergize with each other are responsible for the biological properties of the EO. S. aromaticum is traditionally used for bowel and stomach disorders, cold and flu, oral hygiene, tooth decay, and for its analgesic action. Its EO has shown antioxidant, antimicrobial, anti-inflammatory, neuro-protective, anti-stress, anticancer, and anti-nociceptive activities. This review aims to investigate the role of E. S. aromaticum EO in the counteraction of MDR microorganisms responsible for human disorders, diseases, or infections, such as Escherichia coli , Pseudomonas aeruginosa , Staphylococcus aureus , Salmonella typhi , Candida albicans , Giardia lamblia , Streptococcus mutans , Porphyromonas gingivalis , and Klebsiella pneumoniae . This study might orient clinical researchers on future therapeutic uses of S. aromaticum EO in the prevention and treatment of infectious diseases.
Keyphrases
- multidrug resistant
- essential oil
- biofilm formation
- candida albicans
- klebsiella pneumoniae
- escherichia coli
- staphylococcus aureus
- pseudomonas aeruginosa
- acinetobacter baumannii
- anti inflammatory
- drug resistant
- gram negative
- human health
- infectious diseases
- cystic fibrosis
- oxidative stress
- neuropathic pain
- climate change
- combination therapy
- current status
- spinal cord injury
- spinal cord